Scarica l'app Stockscreener
66.29
0.96%
0.63
Dopo l'orario di chiusura:
66.51
0.22
+0.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$65.66
Aprire:
$66.26
Volume 24 ore:
2.88M
Relative Volume:
1.51
Capitalizzazione di mercato:
$32.33B
Reddito:
$10.63B
Utile/perdita netta:
$819.00M
Rapporto P/E:
39.99
EPS:
1.6577
Flusso di cassa netto:
$1.59B
1 W Prestazione:
-2.20%
1M Prestazione:
-8.95%
6M Prestazione:
-16.42%
1 anno Prestazione:
-23.23%
Intervallo 1D:
$66.19
$67.06
Intervallo di 1 settimana:
$65.36
$68.27
Portata 52W:
$61.84
$92.55
Alcon Inc Stock (ALC) Company Profile
Nome
Alcon Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare ALC vs ISRG, BDX, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
66.29 | 32.02B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
424.64 | 150.03B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.12 | 40.89B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
36.56 | 31.12B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
190.57 | 29.51B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-26 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Iniziato | William Blair | Mkt Perform |
| 2026-01-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Downgrade | Stifel | Buy → Hold |
| 2025-12-11 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-08-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Reiterato | BTIG Research | Buy |
| 2025-03-28 | Reiterato | Needham | Buy |
| 2025-03-25 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-01-24 | Reiterato | Needham | Buy |
| 2025-01-10 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Reiterato | Needham | Buy |
| 2024-11-12 | Reiterato | Needham | Buy |
| 2024-10-10 | Aggiornamento | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Iniziato | Goldman | Buy |
| 2024-03-14 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Iniziato | Bernstein | Outperform |
| 2023-12-18 | Downgrade | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Aggiornamento | Societe Generale | Sell → Hold |
| 2022-12-22 | Iniziato | Mizuho | Buy |
| 2022-11-17 | Downgrade | Societe Generale | Hold → Sell |
| 2022-08-11 | Downgrade | Societe Generale | Buy → Hold |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-05-12 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-11 | Iniziato | BofA Securities | Buy |
| 2022-01-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Iniziato | Oppenheimer | Perform |
| 2021-07-14 | Iniziato | Deutsche Bank | Buy |
| 2021-05-06 | Aggiornamento | Citigroup | Sell → Neutral |
| 2021-03-22 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-11-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-07-06 | Downgrade | Citigroup | Neutral → Sell |
| 2020-07-06 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-04-08 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Aggiornamento | Argus | Hold → Buy |
| 2020-03-24 | Aggiornamento | Societe Generale | Sell → Hold |
| 2020-03-13 | Aggiornamento | UBS | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-26 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-01-08 | Iniziato | Argus | Hold |
| 2019-10-29 | Iniziato | Stephens | Equal-Weight |
| 2019-08-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-06-24 | Iniziato | SVB Leerink | Mkt Perform |
| 2019-06-14 | Iniziato | BTIG Research | Neutral |
| 2019-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Alcon Inc Borsa (ALC) Ultime notizie
Alcon Inc stock (CH0432492467): Eye-care group holds near USD mid-60s as investors track valuation m - AD HOC NEWS
Alcon Inc. stock (CH0432492467): steady trading ahead of next catalysts and valuation focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Swiss-listed shares slip in line with market - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care group steady as investors watch sector trends - AD HOC NEWS
Alcon stock: Earnings, guidance and lens demand in focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after latest earnings and guidance upda - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist in focus after latest earnings - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after latest earnings update - AD HOC NEWS
Alcon Inc stock (CH0432492467): Q1 2026 earnings beat keeps eye-care specialist in focus - AD HOC NEWS
Southpoint Capital Advisors LP's Alcon Inc(ALC) Holding History - GuruFocus
Evaluating Alcon (SWX:ALC) After Recent Share Price Weakness And Perceived Valuation Gap - Yahoo Finance
Baptista Research Upgrades Alcon to Buy Rating - Moomoo
Does Alcon (SWX:ALC) Offer Opportunity After A 26% One Year Share Price Slide? - Yahoo Finance
Alcon Inc. (ALC) Stock Analysis: Eyeing A 29.63% Potential Upside - DirectorsTalk Interviews
Alcon Inc stock (CH0432492467): eye-care specialist in focus after latest quarterly results - AD HOC NEWS
Alcon Inc. stock (CH0432492467): eye-care specialist in focus after latest quarterly results - AD HOC NEWS
Sight Sciences wins $34M patent ruling against Alcon - MSN
UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $109.27 - Moomoo
ALC.S Stock Price, Quote & Chart | ALCON INC (SWX:ALC) - ChartMill
UBS Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $109.47 - Moomoo
Alcon Inc. stock (CH0432492467): contact lens specialist in focus after latest earnings - AD HOC NEWS
Alcon Inc. stock (CH0432492467): eye-care group in focus after Q1 2026 figures - AD HOC NEWS
Alcon stock (CH0432492467): New developments in eye care demand - AD HOC NEWS
Revolution Race Cars names Alcon as brake partner for new HyperSport track car - Tyrepress
ALC Stock Price, Quote & Chart | ALCON INC (NYSE:ALC) - ChartMill
Alcon Inc stock (CH0432492467): eye-care group in focus after Q1 2026 earnings - AD HOC NEWS
Alcon unveils $60M facility expansion in Cabell County - MSN
Alcon Inc. stock (CH0432492467): Q1 2026 earnings and outlook keep eye-care specialist in focus - AD HOC NEWS
Alcon Inc. stock (CH0432492467): latest earnings keep eye?care specialist in focus - AD HOC NEWS
Alcon stock (CH0432492467): Shares jump after May 18 move - AD HOC NEWS
Alcon declines 10% after Q1 revenue misses consensus - MSN
Alcon Inc. stock (CH0432492467): contact lens specialist in focus after latest quarterly update - AD HOC NEWS
Alcon Inc (ALC) Stock Up 3.7% and Still Undervalued -- GF Score: 78/100 - GuruFocus
Earnings Snapshot: Alcon plans to offset FY ~$100M tariff impact, guides profit above consensus - MSN
Alcon Inc. stock (CH0432492467): eye-care specialist in focus after quarterly earnings - AD HOC NEWS
LENSAR stock (US52633C1071): eye-surgery specialist back in focus after Alcon deal collapse - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist in focus after Q1 2025 earnings - AD HOC NEWS
Alcon Inc. stock (CH0432492467): Q1 earnings beat keeps eye-care specialist in focus - AD HOC NEWS
Alcon Inc. (ALC) Sees Mixed Signals After Q1 Beat and Target Reduction - Insider Monkey
Alcon Inc. stock (CH0432492467): contact lens and eye surgery specialist in focus after recent earni - AD HOC NEWS
LENSAR signals 2027 as really, really good year as it rebuilds distributor orders after Alcon deal termination - MSN
Alcon Inc stock (CH0432492467): Impairments announced in Q1 2026 results - AD HOC NEWS
Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $89.72 - Moomoo
Alcon Inc. stock (CH0432492467): Eye health leader navigates competitive market - AD HOC NEWS
Earnings call transcript: Alcon Q1 2026 sees EPS beat but stock dips - Investing.com Canada
Alcon Inc stock (CH0432492467): Eye health leader navigates surgical and vision care markets - AD HOC NEWS
Alcon Inc. stock (CH0432492467): Eye care leader reports Q1 2026 momentum - AD HOC NEWS
ALC.S Technical Analysis | Trend, Signals & Chart Patterns | ALCON INC (SWX:ALC) - ChartMill
Alcon Earnings Call Highlights Growth Amid Margin Strains - The Globe and Mail
Alcon Inc stock (CH0432492467): Eye health leader navigates market challenges - AD HOC NEWS
Alcon Inc. stock (CH0432492467): Eye health leader navigates market dynamics - AD HOC NEWS
Alcon Inc Azioni (ALC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.65%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):